XML 38 R27.htm IDEA: XBRL DOCUMENT v3.21.1
Summary of significant accounting policies - Narrative (Details)
3 Months Ended
Mar. 31, 2021
USD ($)
segment
Mar. 31, 2020
USD ($)
Dec. 31, 2020
USD ($)
Research and Development Expense [Abstract]      
Reverse stock split ratio 0.1667    
Deferred Offering Costs $ 0   $ 0
Research and development expense $ 0 $ 0  
Number of operating segments | segment 1